# Abbott India Ltd (ABBOTINDIA)
> Exchange: NSE | Sector: Pharma | ISIN: INE358A01014

## Price
Current Price: ₹27830
Day Change: +0.41%
52W High: ₹37000
52W Low: ₹25150
Market Cap: ₹58,659 Cr

## Valuation
P/E: 37.85
P/B: 12.29
EPS: ₹729.23
Book Value: ₹2246.69
Dividend Yield: 0%

## Returns
1Y Return: -5.51%

## Profitability
ROE: 34.46%
ROCE: 57.14%
Debt/Equity: 0.04
Revenue Growth: 11.3%
Profit Growth: 7.6%
EBITDA Margin: 30.21%
Operating Margin: 30.1%

## About
Abbott India Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Abbott India Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- BSE Filing: Announcement under Regulation 30 (LODR)-Newspaper Publication

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-24T20:00:00.754Z
Price History Updated: 2026-05-17T21:23:44.678Z
Latest Price History Date: 2026-05-17
Technicals Updated: 2026-05-17T21:23:44.678Z
Quant Updated: 2026-05-17T21:23:44.678Z
Sentiment Updated: 2026-05-17T21:23:44.678Z
Financials Status: current
Financials Updated: 2026-05-18T05:30:12.387Z
Financials Last Attempt: 2026-05-18T05:30:12.387Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹6406.97 Cr
Operating Profit: ₹1644.65 Cr (OPM 25.67%)
Net Profit: ₹1414.44 Cr
Tax: ₹472.51 Cr

## Annual P&L History
FY25: Rev ₹6406.97Cr | PAT ₹1414.44Cr | OPM 25.67%
FY24: Rev ₹5847.19Cr | PAT ₹1201.22Cr | OPM 24.04%
FY23: Rev ₹5346.73Cr | PAT ₹949.41Cr | OPM 21.46%

## Balance Sheet (FY25)
Total Assets: ₹5917.31 Cr
Total Liabilities: ₹1684.16 Cr
Borrowings: ₹196.67 Cr
Cash: ₹560.59 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Kartik  Rajendran, MD & Director
- Maithilee  Mistry, Chief Financial Officer
- Sangeeta Mukesh Shetty, Associate Director - Secretarial, Company Secretary, Nodal Officer & Compliance Officer
- Vinutha  Mufti, Director of Business Human Resources

---
Source: rupiya.io/stocks/abbotindia
Disclaimer: For research and education only. Not investment advice.